Maven Brands Inc. (TRLFF) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
Beta 1.24: the stock has moved about 24% more than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerMaven Brands Inc. (TRLFF) trades at $0.0001. Maven Brands Inc. cultivates, processes, and sells medical cannabis. Formerly known as True Leaf Brands Inc., the company rebranded in November 2021 and is based in Vernon, Canada. Sector: Healthcare.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for TRLFF: TRLFF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Maven Brands Inc. (TRLFF) Healthcare & Pipeline Overview
Maven Brands Inc. operates in the medical cannabis sector, focusing on cultivation, processing, and sales. The company, previously True Leaf Brands Inc., aims to establish itself in the specialty and generic drug manufacturing market within the evolving regulatory landscape of the healthcare industry.
What Is the Investment Thesis for TRLFF?
Maven Brands Inc. (TRLFF) operates in the evolving medical cannabis market. With a negative P/E ratio of -0.28, the company's profitability is currently a concern. The beta of 1.24 indicates higher volatility compared to the market. Growth prospects depend on expanding market access and product innovation. Key value drivers include increasing medical cannabis adoption, regulatory changes favoring the industry, and successful product development. Investors should closely monitor the company's financial performance, regulatory developments, and competitive landscape. The absence of dividends may deter income-focused investors.
Based on FMP financials and quantitative analysis
TRLFF Key Highlights
Maven Brands Inc. operates in the medical cannabis industry, focusing on cultivation, processing, and sales.
- The company was formerly known as True Leaf Brands Inc. and rebranded in November 2021.
- Maven Brands Inc. is based in Vernon, Canada, and was founded in 2013.
- The company's P/E ratio is -0.28, indicating current losses.
- The stock has a beta of 1.24, suggesting higher volatility compared to the market.
Who Are TRLFF's Competitors?
TRLFF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| TAK Takeda Pharmaceutical Company Limited | $17.86 | 0.00% | $56.8B | 64 5-pillar |
| TEVA Teva Pharmaceutical Industries Limited | $39.53 | +0.56% | $46.0B | 66 5-pillar |
| HLN Haleon plc | $8.80 | +0.92% | $38.8B | 78 5-pillar |
| ZTS Zoetis Inc. | $69.69 | +0.85% | $29.2B | 87 5-pillar |
| VTRS Viatris Inc. | $17.60 | +0.80% | $20.5B | 32 5-pillar |
| ELAN Elanco Animal Health Incorporated | $22.14 | +1.70% | $11.1B | 33 5-pillar |
| RDY Dr. Reddy's Laboratories Limited | $12.25 | 0.00% | $10.2B | 81 5-pillar |
| LNTH Lantheus Holdings, Inc. | $99.96 | +0.31% | $6.51B | 91 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are TRLFF's Key Strengths?
Established presence in the medical cannabis market.
- Proprietary cultivation and processing techniques.
- Strong brand reputation.
- Experienced management team.
What Are TRLFF's Weaknesses?
Limited financial resources.
- Dependence on regulatory approvals.
- Intense competition.
- Negative P/E ratio indicating current losses.
What Are the Key Risks for TRLFF?
Financial-distress signal — its Altman Z-Score of -12.97 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Changes in regulations could negatively impact Maven Brands Inc.'s operations.
- Intense competition in the medical cannabis market.
- Fluctuations in cannabis prices could affect profitability.
- Limited financial resources may hinder growth initiatives.
What Threats Does TRLFF Face?
- Changing regulatory landscape.
- Intense competition from larger players.
- Fluctuations in cannabis prices.
- Potential for product recalls or safety concerns.
What Are TRLFF's Competitive Advantages?
- Proprietary cultivation techniques for high-quality cannabis.
- Established relationships with healthcare providers and distributors.
- Strong brand reputation in the medical cannabis market.
- Compliance with regulatory requirements and quality standards.
What Does TRLFF Do?
Maven Brands Inc., formerly known as True Leaf Brands Inc., was founded in 2013 and is headquartered in Vernon, Canada. The company cultivates, processes, and sells medical cannabis. The rebranding to Maven Brands Inc. in November 2021 marked a strategic shift in its corporate identity and market focus. Maven Brands Inc. operates within the burgeoning medical cannabis industry, navigating a complex regulatory environment. The company's core business revolves around cultivating cannabis plants, processing them into various medical cannabis products, and distributing these products through established sales channels. The company aims to capitalize on the increasing acceptance and legalization of medical cannabis across various jurisdictions. Maven Brands Inc. is focused on expanding its product offerings and market reach within the medical cannabis sector. The company's success hinges on its ability to maintain high-quality cultivation standards, navigate regulatory hurdles, and effectively market its products to healthcare providers and patients.
What Products and Services Does TRLFF Offer?
- Cultivates medical cannabis plants.
- Processes cannabis into various medical products.
- Sells medical cannabis products to patients.
- Operates in the healthcare sector.
- Focuses on the specialty and generic drug manufacturing market.
- Navigates the regulatory environment for medical cannabis.
How Does TRLFF Make Money?
- Cultivation and processing of medical cannabis.
- Sales of medical cannabis products to patients and healthcare providers.
- Revenue generation through product sales.
- Focus on expanding market reach and product offerings.
What Industry Does TRLFF Operate In?
Maven Brands Inc. operates within the Drug Manufacturers - Specialty & Generic industry, a segment experiencing growth due to increasing demand for specialized medications and generic alternatives. The medical cannabis sector is rapidly evolving, driven by changing regulations and increasing acceptance of cannabis for medical purposes. Competitors include ELLXF (Elixinol Wellness Limited), MSMY (MYM Nutraceuticals Inc.), NRXCF (NRx Pharmaceuticals, Inc.), PHCG (Pharmagreen Biotech, Inc.), and PRCNF (Pure Canadian Gaming Corp.). The industry faces challenges such as regulatory uncertainty and intense competition.
Who Are TRLFF's Key Customers?
- Patients seeking medical cannabis for various conditions.
- Healthcare providers prescribing medical cannabis.
- Pharmacies and dispensaries selling medical cannabis products.
- Consumers interested in cannabis-based wellness products.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
Maven Brands Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Vernon, CA. The company is led by CEO Darcy E. Bomford. TRLFF has traded publicly since 2017.
Key Financial Metrics
Return on equity for Maven Brands Inc. stands at 438.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -48.6%, showing how much profit it generates from its asset base. A current ratio of 0.10 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
Maven Brands Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -12.97 places it in the distress zone, a signal of elevated financial risk.
TRLFF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
TRLFF Latest News
-
Stocks That Hit 52-Week Lows On Tuesday
· Mar 24, 2020
-
Stocks That Hit 52-Week Lows On Wednesday
· Oct 9, 2019
-
Stocks That Hit 52-Week Lows On Friday
· Aug 16, 2019
TRLFF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for TRLFF.
Price Targets
Wall Street price target analysis for TRLFF.
TRLFF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for TRLFF; grades run from A+ (80-100) to F (below 30).
Leadership: Darcy E. Bomford
CEO
Darcy E. Bomford serves as the CEO of Maven Brands Inc. His background includes experience in the cannabis industry, with a focus on cultivation, processing, and sales. He has been involved in the development and implementation of strategic initiatives to drive growth and market expansion. Bomford's leadership is focused on navigating the regulatory landscape and building a strong brand reputation for Maven Brands Inc.
Track Record: Under Darcy Bomford's leadership, Maven Brands Inc. has undergone a rebranding and strategic shift to focus on the medical cannabis market. Key milestones include expanding product offerings, establishing partnerships with healthcare providers, and navigating regulatory hurdles. His focus is on achieving sustainable growth and profitability for the company.
TRLFF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Maven Brands Inc. may not meet the minimum financial or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting and may not be subject to the same level of regulatory scrutiny as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for limited information and liquidity.
- OTC Tier: OTC Other
- Limited financial disclosure and transparency.
- Low trading volume and liquidity.
- Potential for price manipulation.
- Higher risk of fraud or mismanagement.
- Limited regulatory oversight.
- Verify the company's legal status and registration.
- Review available financial statements and disclosures.
- Assess the company's management team and track record.
- Research the company's business model and competitive landscape.
- Evaluate the company's regulatory compliance.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor.
- Company has a functioning website and contact information.
- Company has been in operation for several years.
- Company has a physical address and identifiable employees.
- Company is actively involved in the medical cannabis industry.
- Company has obtained necessary licenses and permits.
TRLFF Healthcare Stock FAQ
What do analysts say about TRLFF stock?
There is currently no available analyst coverage or consensus on Maven Brands Inc. (TRLFF). Given its OTC listing and limited financial information, it is difficult to assess key valuation metrics and growth considerations.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited financial information available for Maven Brands Inc.
- OTC stocks carry higher risks compared to exchange-listed stocks.